| Product Code: ETC5311299 | Publication Date: Nov 2023 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
In 2024, the Netherlands continued to see a steady increase in pulmonary/respiratory drug delivery import shipments, with key exporting countries being Germany, USA, Ireland, Belgium, and Italy. The market showed moderate concentration with a Herfindahl-Hirschman Index (HHI) remaining stable. The compound annual growth rate (CAGR) from 2020-2024 was a healthy 5.02%, indicating sustained growth in the sector. The growth rate from 2023-2024 was 0.84%, suggesting a consistent upward trajectory in the import of pulmonary/respiratory drug delivery products to the Netherlands.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Netherlands Pulmonary/ Respiratory Drug Delivery Market Overview |
3.1 Netherlands Country Macro Economic Indicators |
3.2 Netherlands Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume, 2021 & 2031F |
3.3 Netherlands Pulmonary/ Respiratory Drug Delivery Market - Industry Life Cycle |
3.4 Netherlands Pulmonary/ Respiratory Drug Delivery Market - Porter's Five Forces |
3.5 Netherlands Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume Share, By Formulations, 2021 & 2031F |
3.6 Netherlands Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume Share, By Canister Type, 2021 & 2031F |
3.7 Netherlands Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume Share, By Applications, 2021 & 2031F |
3.8 Netherlands Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Netherlands Pulmonary/ Respiratory Drug Delivery Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of respiratory diseases in the Netherlands |
4.2.2 Growing geriatric population leading to higher demand for pulmonary drug delivery |
4.2.3 Technological advancements in respiratory drug delivery devices |
4.2.4 Rising awareness about the importance of early diagnosis and treatment of respiratory disorders |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of respiratory drug delivery devices |
4.3.2 High cost associated with advanced pulmonary drug delivery systems |
4.3.3 Limited reimbursement policies for respiratory medications |
4.3.4 Competition from alternative therapies such as inhalation therapy |
5 Netherlands Pulmonary/ Respiratory Drug Delivery Market Trends |
6 Netherlands Pulmonary/ Respiratory Drug Delivery Market Segmentations |
6.1 Netherlands Pulmonary/ Respiratory Drug Delivery Market, By Formulations |
6.1.1 Overview and Analysis |
6.1.2 Netherlands Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume, By Type, 2021-2031F |
6.1.3 Netherlands Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume, By Device Type, 2021-2031F |
6.2 Netherlands Pulmonary/ Respiratory Drug Delivery Market, By Canister Type |
6.2.1 Overview and Analysis |
6.2.2 Netherlands Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume, By Plain Canister, 2021-2031F |
6.2.3 Netherlands Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume, By Coated Canister, 2021-2031F |
6.3 Netherlands Pulmonary/ Respiratory Drug Delivery Market, By Applications |
6.3.1 Overview and Analysis |
6.3.2 Netherlands Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume, By Asthma, 2021-2031F |
6.3.3 Netherlands Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume, By COPD, 2021-2031F |
6.3.4 Netherlands Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume, By Cystic Fibrosis, 2021-2031F |
6.4 Netherlands Pulmonary/ Respiratory Drug Delivery Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Netherlands Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume, By Hospitals & Clinics, 2021-2031F |
6.4.3 Netherlands Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume, By Homecare settings, 2021-2031F |
7 Netherlands Pulmonary/ Respiratory Drug Delivery Market Import-Export Trade Statistics |
7.1 Netherlands Pulmonary/ Respiratory Drug Delivery Market Export to Major Countries |
7.2 Netherlands Pulmonary/ Respiratory Drug Delivery Market Imports from Major Countries |
8 Netherlands Pulmonary/ Respiratory Drug Delivery Market Key Performance Indicators |
8.1 Patient adherence rates to pulmonary drug delivery regimens |
8.2 Number of clinical trials and research studies conducted on respiratory drug delivery in the Netherlands |
8.3 Adoption rate of innovative respiratory drug delivery technologies |
8.4 Rate of hospital readmissions for respiratory conditions |
8.5 Percentage of healthcare professionals trained in proper use of pulmonary drug delivery devices |
9 Netherlands Pulmonary/ Respiratory Drug Delivery Market - Opportunity Assessment |
9.1 Netherlands Pulmonary/ Respiratory Drug Delivery Market Opportunity Assessment, By Formulations, 2021 & 2031F |
9.2 Netherlands Pulmonary/ Respiratory Drug Delivery Market Opportunity Assessment, By Canister Type, 2021 & 2031F |
9.3 Netherlands Pulmonary/ Respiratory Drug Delivery Market Opportunity Assessment, By Applications, 2021 & 2031F |
9.4 Netherlands Pulmonary/ Respiratory Drug Delivery Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Netherlands Pulmonary/ Respiratory Drug Delivery Market - Competitive Landscape |
10.1 Netherlands Pulmonary/ Respiratory Drug Delivery Market Revenue Share, By Companies, 2024 |
10.2 Netherlands Pulmonary/ Respiratory Drug Delivery Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |